Aurobindo Pharma shares in focus after USFDA issues 11 observations at Unit III

February 9, 2026
Uncategorized

The inspection, which was carried out between January 27 and February 6, resulted in 11 observations being issued to the plant. Unit III is a formulations manufacturing facility.

Aurobindo Pharma shares in focus after USFDA issues 11 observations at Unit III

Leave a ReplyCancel Reply

Tokyo benchmark Nikkei 225 jumps after PM Takaichi’s ruling party wins a super majority in election

Kaynes Technology shares rise 4% after CLSA upgrade despite target cut

Patanjali Foods shares decline as 1.48% equity worth ₹272 crore changes hands in block deals

JK Tyre shares jump 5% after healthy Q3, management guides margin above 13%

Explained: Why PSU banks are red hot today